Role of Platelets and Platelet Receptors in Cancer Metastasis

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2018 Oct 12

PMID 30305116

Citations 286

Authors

Martin Schlesinger

Affiliations

Soon will be listed here.

Abstract

The interaction of tumor cells with platelets is a prerequisite for successful hematogenous metastatic dissemination. Upon tumor cell arrival in the blood, tumor cells immediately activate platelets to form a permissive microenvironment. Platelets protect tumor cells from shear forces and assault of NK cells, recruit myeloid cells by secretion of chemokines, and mediate an arrest of the tumor cell platelet embolus at the vascular wall. Subsequently, platelet-derived growth factors confer a mesenchymal-like phenotype to tumor cells and open the capillary endothelium to expedite extravasation in distant organs. Finally, platelet-secreted growth factors stimulate tumor cell proliferation to micrometastatic foci. This review provides a synopsis on the current literature on platelet-mediated effects in cancer metastasis and particularly focuses on platelet adhesion receptors and their role in metastasis. Immunoreceptor tyrosine-based activation motif (ITAM) and hemi ITAM (hemITAM) comprising receptors, especially, glycoprotein VI (GPVI), FcγRIIa, and C-type lectin-like-2 receptor (CLEC-2) are turned in the spotlight since several new mechanisms and contributions to metastasis have been attributed to this family of platelet receptors in the last years.

Citing Articles

Value of brief hematological characteristics in differentiating carcinoembryonic-antigen-negative colorectal cancer from benign colorectal diseases.

Yi L, Lao X, Lu L, Zhu C, Zhou D, Li S World J Gastrointest Surg. 2025; 17(2):101403.

PMID: 40061991 PMC: 11885996. DOI: 10.4240/wjgs.v17.i2.101403.

Calcium levels modulate platelet function, platelet-cancer cell interaction, and cancer cell invasion.

Morris K, Masri S, Schnoor B, Papa A Sci Rep. 2025; 15(1):7750.

PMID: 40044703 PMC: 11883003. DOI: 10.1038/s41598-024-79280-8.

Prognostic significance of systemic immune inflammation index for ovarian cancer: An updated systematic review and meta-analysis.

Chu B, Chen Y, Pan J J Ovarian Res. 2025; 18(1):41.

PMID: 40016853 PMC: 11869409. DOI: 10.1186/s13048-025-01626-1.

Comprehensive analysis of CLEC family genes in gastric cancer prognosis immune response and treatment.

Zhu W, Yi Q, Wang J, Ouyang X, Yang K, Jiang B Sci Rep. 2025; 15(1):5956.

PMID: 39966377 PMC: 11836380. DOI: 10.1038/s41598-024-80204-9.

Prognostic evaluation of non-muscle invasive bladder cancer with P-CRP and its nomogram.

Wu J, Deng Z, Lei X, Xu Z, Tan C, Tang Y Front Oncol. 2025; 15:1406585.

PMID: 39963109 PMC: 11830596. DOI: 10.3389/fonc.2025.1406585.

References

Parker C, Stone O, White V, Bernshaw N . Vitronectin (S protein) is associated with platelets. Br J Haematol. 1989; 71(2):245-52. DOI: 10.1111/j.1365-2141.1989.tb04262.x. View

Berndt M, Gregory C, Kabral A, Zola H, Fournier D, Castaldi P . Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem. 1985; 151(3):637-49. DOI: 10.1111/j.1432-1033.1985.tb09152.x. View

Tuszynski G, Kowalska M . Thrombospondin-induced adhesion of human platelets. J Clin Invest. 1991; 87(4):1387-94. PMC: 295181. DOI: 10.1172/JCI115144. View

Boulaftali Y, Hess P, Kahn M, Bergmeier W . Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res. 2014; 114(7):1174-84. PMC: 4000726. DOI: 10.1161/CIRCRESAHA.114.301611. View

Gil-Bernabe A, Ferjancic S, Tlalka M, Zhao L, Allen P, Im J . Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood. 2012; 119(13):3164-75. DOI: 10.1182/blood-2011-08-376426. View

Canobbio I, Balduini C, Torti M . Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal. 2004; 16(12):1329-44. DOI: 10.1016/j.cellsig.2004.05.008. View

Erpenbeck L, Nieswandt B, Schon M, Pozgajova M, Schon M . Inhibition of platelet GPIb alpha and promotion of melanoma metastasis. J Invest Dermatol. 2009; 130(2):576-86. DOI: 10.1038/jid.2009.278. View

Melnikova V, Mourad-Zeidan A, Lev D, Bar-Eli M . Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem. 2005; 281(5):2911-22. DOI: 10.1074/jbc.M508683200. View

Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D . Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res. 2005; 67(1):30-8. DOI: 10.1016/j.cardiores.2005.04.007. View

10.

Shen J, Pavone A, Mikulec C, Hensley S, Traner A, Chang T . Protein expression profiles in the epidermis of cyclooxygenase-2 transgenic mice by 2-dimensional gel electrophoresis and mass spectrometry. J Proteome Res. 2007; 6(1):273-86. DOI: 10.1021/pr060418h. View

11.

Baglia F, Badellino K, Li C, Lopez J, Walsh P . RETRACTED: Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem. 2001; 277(3):1662-8. DOI: 10.1074/jbc.M108319200. View

12.

Oleksowicz L, Bhagwati N . Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies. Cancer Res. 1999; 59(9):2244-50. View

13.

Ruggeri Z . Platelets in atherothrombosis. Nat Med. 2002; 8(11):1227-34. DOI: 10.1038/nm1102-1227. View

14.

Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I . Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med. 2010; 2(47):47ra63. DOI: 10.1126/scitranslmed.3001001. View

15.

Hilgard P . The role of blood platelets in experimental metastases. Br J Cancer. 1973; 28(5):429-35. PMC: 2008922. DOI: 10.1038/bjc.1973.168. View

16.

Watanabe M, Okochi E, Sugimoto Y, Tsuruo T . Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies. Cancer Res. 1988; 48(22):6411-6. View

17.

Bambace N, Levis J, Holmes C . The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Platelets. 2010; 21(2):85-93. DOI: 10.3109/09537100903470298. View

18.

Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff D, Ruggeri Z . Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost. 2006; 4(9):2014-21. DOI: 10.1111/j.1538-7836.2006.02086.x. View

19.

. Selectins and mechanisms of signal transduction. J Leukoc Biol. 1998; 63(1):1-14. View

20.

Suzuki-Inoue K, Inoue O, Ozaki Y . Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost. 2011; 9 Suppl 1:44-55. DOI: 10.1111/j.1538-7836.2011.04335.x. View